Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Aethlon Medical, Inc. (AEMD)

Compare
0.3504
+0.0011
+(0.31%)
At close: April 4 at 4:00:03 PM EDT
0.3500
-0.00
(-0.11%)
After hours: April 4 at 7:46:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
--
--
574.2450
294.1650
659.1040
Operating Expense
9,823.3760
12,636.5680
12,472.8830
10,715.0500
8,550.6030
Operating Income
-9,823.3760
-12,636.5680
-11,898.6380
-10,420.8850
-7,891.4990
Net Non Operating Interest Income Expense
264.7620
428.3940
10.9730
--
-1.5800
Other Income Expense
--
--
-142.1210
--
--
Pretax Income
-9,558.6140
-12,208.1740
-12,029.7860
-10,420.8850
-7,891.4990
Net Income Common Stockholders
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Diluted NI Available to Com Stockholders
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Basic EPS
-1.52
-4.86
-5.90
-7.10
-6.50
Diluted EPS
-1.52
-4.86
-5.90
-7.10
-6.50
Basic Average Shares
9,506.0540
2,512.7740
2,053.7430
1,475.6960
1,209.0880
Diluted Average Shares
9,506.0540
2,512.7740
2,053.7430
1,475.6960
1,209.0880
Total Operating Income as Reported
-9,823.3760
-12,636.5680
-11,898.6380
-10,420.8850
-7,891.4990
Total Expenses
9,823.3760
12,636.5680
12,472.8830
10,715.0500
8,550.6030
Net Income from Continuing & Discontinued Operation
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Normalized Income
-9,558.6140
-12,208.1740
-11,887.6650
-10,416.0910
-7,886.7090
Interest Income
264.7620
428.3940
10.9730
--
--
Interest Expense
--
--
--
--
1.5800
Net Interest Income
264.7620
428.3940
10.9730
--
-1.5800
EBIT
-9,823.3760
-12,636.5680
-11,898.6380
-10,420.8850
-7,891.4990
EBITDA
-9,481.8490
-12,277.5110
-11,657.7460
-10,297.2000
-7,851.5600
Reconciled Depreciation
341.5270
359.0570
240.8920
123.6850
39.9390
Net Income from Continuing Operation Net Minority Interest
-9,558.6140
-12,208.1740
-12,029.7860
-10,416.0910
-7,886.7090
Total Unusual Items Excluding Goodwill
--
--
-142.1210
--
--
Total Unusual Items
--
--
-142.1210
--
--
Normalized EBITDA
-9,481.8490
-12,277.5110
-11,515.6250
-10,297.2000
-7,851.5600
3/31/2021 - 3/4/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CTSO Cytosorbents Corporation
0.9700
-2.02%
 
BIOVIT.ST Bio Vitos Pharma AB (publ)
0.2160
+60.59%
 
SPEC.ST SpectraCure AB (publ)
1.7000
-6.49%
 
QLINEA.ST Q-linea AB (publ)
0.0356
-5.57%
 
QLIFE.ST Qlife Holding AB (publ)
1.9900
-3.40%
 
VTAK Catheter Precision, Inc.
0.3216
-4.03%
 
BSGM BioSig Technologies, Inc.
0.5150
+3.00%
 
NAOV NanoVibronix, Inc.
2.3600
+1.29%
 
XTNT Xtant Medical Holdings, Inc.
0.4700
-0.02%
 
AIMD Ainos, Inc.
0.5250
-3.67%